NATCO estimates the current market size of CTPR containing products in India to be over Rs 2000 crores
Natco Pharma Limited has announced that the company has received order from Hon’ble High Court of Delhi stating that NATCO is allowed to launch Chlorantraniliprole (CTPR) and its formulations, through its non-infringing process.
NATCO, which has diversified into agrichemicals a few years ago, said that it is the first Company in India to have received its registration approval given by Central Insecticide Board & Registration Committee (CIB&RC) recorded in its Minutes of the 425th Meeting held on January 25th, 2021, for indigenous manufacture of Chlorantraniliprole (CTPR) Technical 93.00 per cent w/w min. under Section 9(3).
CTPR technical is formulated into broad-spectrum insecticides used across wide range of crops for pest management. NATCO estimates the current market size of CTPR containing products in India to be over Rs 2000 crores. The Company plans to launch its products very shortly.
